↓ Skip to main content

Dove Medical Press

Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer

Overview of attention for article published in Breast cancer targets and therapy, May 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
53 Mendeley